Table 1.
Clinical features of the investigated patients.
| Features | HFS (n = 11) | CIN 3 (n = 20) | p value∗ | |
|---|---|---|---|---|
| Age, years | Median (min-max) | 42 (32-69) | 35 (19-48) | 0.036 |
|
| ||||
| Value, n (%) | Value, n (%) | |||
|
| ||||
| Categorized age | <30 years | − | 6 (30.0%) | |
| 30–49 years | 8 (72.7%) | 14 (70.0%) | ||
| >50 years | 3 (27.3%) | − | ||
|
| ||||
| hr-HPV | Negative | 7 (63.7%) | 1 (5.0%) | |
| HPV 16 | − | 5 (25.0%) | ||
| HPV 18 | − | 1 (5.0%) | ||
| HPV others | 4 (36.3%) | 8 (40.0%) | ||
| HPV 16 + others | − | 5 (25.0%) | ||
HFS: healthy female subjects without cervical intraepithelial neoplasia (CIN); CIN 3: cervical intraepithelial neoplasia grade 3; hr-HPV: high-risk human papillomavirus; Min: minimum; Max: maximum. ∗The Mann–Whitney test was performed to evaluate age between the biological groups. p < 0.05.